Literature DB >> 7446422

Exercise testing early after myocardial infarction: predictive value for subsequent unstable angina and death.

M R Starling, M H Crawford, G T Kennedy, R A O'Rourke.   

Abstract

Recently, modified treadmill exercise testing before hospital discharge has been reported to be safe in patients after uncomplicated myocardial infarction. Accordingly, the frequency of treadmill exercise-induced abnormalities and their prognostic value were evaluated in 130 patients with uncomplicated myocardial infarction. Seventy-eight patients (60 percent) had one or more treadmill exercise-induced abnormalities; 42 had S-T segment depression, 35 had angina and 17 had an inadequate blood pressure response. During the mean follow-up period of 11 months, 27 patients experienced unstable angina, 12 had a recurrent myocardial infarction and 10 died of cardiac causes. Compared with patients with no exercise-induced abnormality, patients with S-T segment depression, angina pectoris or an inadequate blood pressure response had a significantly greater (p < 0.001) incidence of all cardiac events during the follow-up period. Furthermore, unstable angina pectoris was significantly more frequent (p < 0.005) in patients with S-T segment depression or angina pectoris. Finally, when the patients with ischemic treadmill abnormalities were combined with the patients exhibiting an inadequate blood pressure response, they had a statistically greater (p < 0.005) incidence of cardiac death than that of patients with no treadmill abnormalities. Therefore, these three abnormalities during modified treadmill exercise testing before hospital discharge identify patients with uncomplicated myocardial infarction who are at risk for a future cardiac event.

Entities:  

Mesh:

Year:  1980        PMID: 7446422     DOI: 10.1016/0002-9149(80)90344-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

Review 1.  Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.

Authors:  John J Mahmarian; Girish Dwivedi; Tultul Lahiri
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

2.  The VANQWISH Trial: support for the noninvasive strategy for risk stratification after acute myocardial infarction.

Authors:  G A Beller; K A Brown
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

Review 3.  Stratifying risk after a myocardial infarction.

Authors:  N F Goldschlager
Journal:  West J Med       Date:  1988-07

4.  Non Q wave infarction: exercise test characteristics, coronary anatomy, and prognosis.

Authors:  J P Fox; J M Beattie; M S Salih; M K Davies; W A Littler; R G Murray
Journal:  Br Heart J       Date:  1990-03

5.  Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients.

Authors:  S Basu; R Senior; C Dore; A Lahiri
Journal:  BMJ       Date:  1996-10-05

Review 6.  Beta adrenoceptor antagonists after myocardial infarction--where are we now?

Authors:  D A Chamberlain
Journal:  Br Heart J       Date:  1983-02

7.  Thallium 201 perfusion imaging after the treatment of unstable angina pectoris--relationship to clinical outcome.

Authors:  M C Hillert; K A Narahara; T C Smitherman; L L Burden; J C Wyatt
Journal:  West J Med       Date:  1986-09

8.  Early exercise testing after treatment with thrombolytic drugs for acute myocardial infarction: importance of reciprocal ST segment depression.

Authors:  R N Stevenson; V Umachandran; K Ranjadayalan; R H Roberts; A D Timmis
Journal:  BMJ       Date:  1994-05-07

9.  Submaximal exercise testing early after myocardial infarction. Prognostic importance of exercise induced ST segment elevation.

Authors:  I D Sullivan; D W Davies; E Sowton
Journal:  Br Heart J       Date:  1984-08

10.  Role of exercise testing early after myocardial infarction in identifying candidates for coronary surgery.

Authors:  K Jennings; D S Reid; T Hawkins; D J Julian
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.